课题基金 / 基金详情

POPULATION GENETICS ANALYSIS PROGRAM

POPULATION GENETICS ANALYSIS PROGRAM
群体遗传学分析计划
批准号:
9100516
负责人:
MARK LOEB
金额:
$4.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-30 至 2017-06-29

项目摘要

项目成果

MARK LOEB的其他基金

相似基金

相关文献

中文摘要
翻译
人口遗传学分析计划的重点是针对人类病原体接种疫苗或由人类病原体感染引起的差异免疫反应的人类遗传变异。我们的目标是复制先前确定的人类基因-表型关联,并阐明与免疫结果相关的已验证遗传变异的功能相关性。研究重点将集中在http://www3.niaid.nih.gov/topics/emerging/list.htm.列出的一种或多种新出现或重新出现的I、II或III类传染病病原体上这些信息将有助于识别个体风险因素,将扩大我们对适用于广泛人类疾病的免疫机制的理解,并将有助于定义风险和免疫的生物标记物,这些生物标记物可能导致新的感染诊断测试或疫苗反应。
英文摘要
The Population Genetics Analysis program is focused on human genetic variation underlying differential immune responses to vaccination against or infection by human pathogens. The goals are to replicate previously identified human genotype-phenotype associations and elucidate the functional relevance of the validated genetic variants that correlate with immune outcome. Research will focus on one or more of the emerging or re-emerging Group I, II, or III infectious agents listed at http://www3.niaid.nih.gov/topics/emerging/list.htm. This information will help to identify individual risk factors, will expand our understanding of immune mechanisms applicable to a broad range of human diseases, and will help define biomarkers of risk and immunity that might lead to novel diagnostic tests of infection or vaccine response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
POPULATION GENETICS ANALYSIS PROGRAM
  • 批准号:
    8164204
  • 项目类别:
  • 资助金额:
    $1000.0万
  • 财政年份:
    2010
  • 负责人:
    MARK LOEB
  • 依托单位:
A randomized trial of influenza vaccination of Hutterite children
  • 批准号:
    7694332
  • 项目类别:
  • 资助金额:
    $50.88万
  • 财政年份:
    2008
  • 负责人:
    MARK LOEB
  • 依托单位:
A randomized trial of influenza vaccination of Hutterite children
  • 批准号:
    7527413
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2008
  • 负责人:
    MARK LOEB
  • 依托单位:
A randomized trial of influenza vaccination of Hutterite children
  • 批准号:
    7920229
  • 项目类别:
  • 资助金额:
    $51.49万
  • 财政年份:
    2008
  • 负责人:
    MARK LOEB
  • 依托单位:
海外基金